Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Davì G et al. |
Increased thromboxane metabolites excretion in liver cirrhosis. |
1998 |
Thromb. Haemost. |
pmid:9569186
|
Lessiani G et al. |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. |
2011 |
Thromb. Haemost. |
pmid:21103664
|
Wang JS et al. |
Effect of strenuous arm exercise on oxidized-LDL-potentiated platelet activation in individuals with spinal cord injury. |
2000 |
Thromb. Haemost. |
pmid:10928481
|
Halawani SH et al. |
Aspirin failure in patients presenting with acute cerebrovascular ischaemia. |
2011 |
Thromb. Haemost. |
pmid:21544317
|
Fruzzetti F et al. |
Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. |
1999 |
Thromb. Haemost. |
pmid:10494782
|
Véricel E et al. |
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. |
2015 |
Thromb. Haemost. |
pmid:25832443
|
Forastiero R et al. |
Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. |
1998 |
Thromb. Haemost. |
pmid:9459320
|
Koudstaal PJ et al. |
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. |
1993 |
Stroke |
pmid:8421822
|
Tohgi H et al. |
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. |
1992 |
Stroke |
pmid:1412574
|
Bruno A et al. |
Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. |
2002 |
Stroke |
pmid:11779889
|
Bruno A et al. |
Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. |
2004 |
Stroke |
pmid:14963281
|
van Kooten F et al. |
Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. |
1999 |
Stroke |
pmid:10066850
|
van Kooten F et al. |
Evidence for episodic platelet activation in acute ischemic stroke. |
1994 |
Stroke |
pmid:8303731
|
van Kooten F et al. |
Platelet activation and lipid peroxidation in patients with acute ischemic stroke. |
1997 |
Stroke |
pmid:9259748
|
van Kooten F et al. |
Increased thromboxane biosynthesis is associated with poststroke dementia. |
1999 |
Stroke |
pmid:10436098
|
Gonzalez-Conejero R et al. |
Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? |
2005 |
Stroke |
pmid:15604423
|
Simeoni S et al. |
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. |
2011 |
Stress |
pmid:21434833
|
Haubelt H et al. |
Can platelet function tests predict the clinical efficacy of aspirin? |
2005 |
Semin. Thromb. Hemost. |
pmid:16149017
|
Bruce EC et al. |
Platelet thromboxane A2 secretion in patients with major depression responsive to electroconvulsive therapy. |
2008 |
Psychosom Med |
pmid:18378867
|